Outlook Business Desk
Tata Consultancy Services (TCS) on Friday announced a robust 9.3 per cent YoY jump in March quarter profit at Rs 12,502 crore compared to Rs 11,436 crore in the year-ago period. The company reported revenue growth of Rs 3.5 per cent YoY to Rs 61,237 crore as against Rs 59,162 crore.
The wealth management company reported a consolidated net profit of Rs 57 crore for the March 2024 quarter, an increase of 33 per cent compared to Rs 42.7 crore in the same quarter of FY23. Revenue from operations jumped 34 per cent to Rs 197.2 crore in March quarter compared to Rs 147.1 crore in the year-ago period.
The IT major diluted its stake in FPEL Ujwal Private Limited to 7.07 per cent from 9.95 per cent. In September last year, the company signed a definitive agreement to subscribe for the equity share capital FPEL Ujwal for a value of Rs 6.3 crore. The transaction was expected to be completed before 31 May 2024.
The company’s board has approved a special dividend of Rs 118 per equity share post receipt of proceeds from the sales of its GCC business. The special dividend will be payable to those shareholders whose names stand on the register of company members as of April 23- the record date set for the dividend. The dividend will be paid within 30 days.
The company announced that its unit V facility located at Anakapally, Visakhapatnam, Andhra Pradesh, India, underwent an inspection from the United States Food and Drug Administration (US FDA) from 8 April 2024 to 12 April 2024. The inspection concluded in 'zero' 483 observations. The unit manufactures APIs and formulations for oncology and non-oncology products.